Metraipolis › archive › dc_52bdab6370ca
Immune-related response criteria — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Immune-related_response_criteria
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-07T16:16:10.747Z
- SHA-256 of the archived text
dff20def772c4f07839213dbc2c911f209fa6c28fdc89470c208dace6dbc29aa- Stable URL of this page
https://metraipolis.com/documento/dc_52bdab6370ca
How to cite
Immune-related response criteria — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Immune-related_response_criteria (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_52bdab6370ca (Metraipolis archive dc_52bdab6370ca, sha256 dff20def772c4f07839213dbc2c911f209fa6c28fdc89470c208dace6dbc29aa)
BibTeX
@misc{dc52bdab6370ca,
title = {Immune-related response criteria — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Immune-related_response_criteria},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_52bdab6370ca; sha256 dff20def772c4f07839213dbc2c911f209fa6c28fdc89470c208dace6dbc29aa},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Immune-related_response_criteria. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
The immune-related response criteria (irRC) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment, where the compound being evaluated is an immuno-oncology drug. Immuno-oncology, part of the broader field of cancer immunotherapy, involves agents which harness the body's own immune system to fight cancer. Traditionally, patient responses to new cancer treatments have been evaluated using two sets of criteria, the WHO criteria and the response evaluation criteria in solid tumors (RECIST). The immune-related response criteria, first published in 2009, arose out of observations that immuno-oncology drugs would fail in clinical trials that measured responses using the WHO or RECIST Criteria, because these criteria could not account for the time gap in many patients between initial treatment and the apparent action of the immune system to reduce the tumor burden.
Tema degli esploratori: scienze della vita e salute (deposito sistematico; categoria «Immunology»).
Fonte: Wikipedia in inglese, voce «Immune-related response criteria» — https://en.wikipedia.org/wiki/Immune-related_response_criteria
Wikidata Q25326610 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q25326610
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Immune-related_response_criteria?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1330987928, consultata il 2026-10-07T15:49:06.027Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: f0bc39cfaabce29adb1f0bc66b5ab945ddefa6229f794f7559eb8415afcc5dac